The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Share
More article options
Full text access
Does therapy with spironolactone increase the effect of ACEIs and ARA-II for managing proteinuria and renal failure progression in patients with chronic renal disease?
¿El tratamiento con espironolactona incrementa el efecto de IECAS y ARAII en el control de la proteinuria y la progresión de la insuficiencia renal en pacientes con ERC?
Visits
3741
A. Ramos, C. Caramelo
This item has received
Article information




